To the contrary, salivary IgA from COVID-19–recovered vaccinees displayed a much broader range of cross-reactivity against Beta and Omicron (BA.1, BA.2) STs after the first and second mRNA vaccines (Figure 4, C, F, and G). Here, CD79A is linked to COVID-19.